The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Recruiting
Observational Study
Cancer of Stomach
Oesophageal Cancer
Gastric Cancer
Gastric Adenocarcinoma
GI Cancer
GIST
Neuroendocrine Tumors
Gastric Neoplasm
Esophageal Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Western Sydney Local Health District · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* UGI neoplastic lesions \> 10mm
* Lesions for ESD limited to the mucosal and/or submucosal layer OR
* Lesions for EFTR limited to the muscularis propria layer OR
* Lesions for STER limited to the submucosal and/or muscularis propria layer
* Aged 18 years or older
Exclus…
Contacts